Bioequivalence testing guideline for combination drugs to be made public

The Korea Food and Drug Administration is considering formulating a detailed rule concerning bioequivalence testing of combined preparations after consultation with the industry, as the bioequivalence testing for combination drugs become mandatory from this year.

The drug agency noted that in case a manufacturing license is sought for a combination drug whose contents in active ingredients a...